Compugen | CGEN - Market Capitalization


Compugen reported $558.53M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 2.43B 963M Mar/2026
Bio Path USD 1000K 0 Mar/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Cara Therapeutics USD 30M 336M Mar/2026
Clal Biotechnology ILS 52.36M 2.09M Mar/2025
Compugen USD 620.29M 475.62M Mar/2026
Immunic USD 64M 23M Dec/2025
RedHill Biopharma USD 5M 2M Dec/2025